{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:09:05Z","timestamp":1787630945411,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>The efficacy of azithromycin to prevent exacerbation for non-cystic fibrosis bronchiectasis remains controversial. We conduct this meta-analysis to explore the influence of azithromycin versus placebo for the treatment of non-cystic fibrosis bronchiectasis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We have searched PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases through July 2019 for randomized controlled trials (RCTs) assessing the efficacy of azithromycin versus placebo for non-cystic fibrosis bronchiectasis. This meta-analysis was performed using the random-effect model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Four RCTs were included in the meta-analysis. Overall, compared with control group for non-cystic-fibrosis bronchiectasis, azithromycin treatment was associated with improved free of exacerbation (odd ratios [OR]\u2009=\u20093.66; 95% confidence interval [CI]\u2009=\u20091.69\u20137.93;<jats:italic>P<\/jats:italic>\u2009=\u20090.001), reduced pulmonary exacerbations (OR\u2009=\u20090.27; 95% CI 0.13\u20130.59;<jats:italic>P<\/jats:italic>\u2009=\u20090.001) and number of pulmonary exacerbations (standard mean difference [SMD]\u2009=\u2009\u2009\u2212\u20090.87; 95% CI\u2009\u2212\u20091.21 to\u2009\u2212\u20090.54;<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.00001), but demonstrate no obvious impact on forced expiratory volume in 1\u00a0s (FEV1), score on St George\u2019s respiratory questionnaire, nausea or vomiting, adverse events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Azithromycin is effective to prevent exacerbation of non-cystic fibrosis bronchiectasis.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13019-022-01882-y","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T21:03:01Z","timestamp":1665522181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The efficacy of azithromycin to prevent exacerbation of non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled studies"],"prefix":"10.1186","volume":"17","author":[{"given":"Kui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,11]]},"reference":[{"issue":"18","key":"1882_CR1","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMra012519","volume":"346","author":"AF Barker","year":"2002","unstructured":"Barker AF. Bronchiectasis. N Engl J Med. 2002;346(18):1383\u201393.","journal-title":"N Engl J Med"},{"issue":"2","key":"1882_CR2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1183\/09031936.00069007","volume":"31","author":"S Fuschillo","year":"2008","unstructured":"Fuschillo S, De Felice A, Balzano G. Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms. Eur Respir J. 2008;31(2):396\u2013406.","journal-title":"Eur Respir J"},{"key":"1882_CR3","doi-asserted-by":"crossref","unstructured":"Ramsey K, Radicioni G, Hill D, Ehre C, Button B, Alexis NE, Knowles M, Donaldson S, Kesimer M, Mcguckin M. Airways mucus pathogenesis in patients with non-cystic fibrosis bronchiectasis. Eur Respiratory Soc. 2018.","DOI":"10.1183\/13993003.congress-2018.PA5049"},{"issue":"3","key":"1882_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/MCP.0000000000000569","volume":"25","author":"P Chang-Macchiu","year":"2019","unstructured":"Chang-Macchiu P, Traversi L, Polverino E. Bronchiectasis phenotypes. Curr Opin Pulm Med. 2019;25(3):281\u20138.","journal-title":"Curr Opin Pulm Med"},{"issue":"7","key":"1882_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/17476348.2018.1481392","volume":"12","author":"R Athanazio","year":"2018","unstructured":"Athanazio R, da Costa JC, de la Rosa Carrillo D, Mart\u00ednez-Garc\u00eda M\u00c1. Current and future pharmacotherapy options for non-cystic fibrosis bronchiectasis. Expert Rev Respir Med. 2018;12(7):569\u201384.","journal-title":"Expert Rev Respir Med"},{"issue":"3","key":"1882_CR6","doi-asserted-by":"publisher","first-page":"1800328","DOI":"10.1183\/13993003.00328-2018","volume":"52","author":"E Polverino","year":"2018","unstructured":"Polverino E, Dimakou K, Hurst J, Martinez-Garcia M-A, Miravitlles M, Paggiaro P, Shteinberg M, Aliberti S, Chalmers JD. The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. Eur Respir J. 2018;52(3):1800328.","journal-title":"Eur Respir J"},{"issue":"7","key":"1882_CR7","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/resp.12130","volume":"18","author":"AD Diego","year":"2013","unstructured":"Diego AD, Milara J, Martinez-Morag\u00f3n E, Palop M, Le\u00f3n M, Cortijo J. Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchiectasis. Respirology. 2013;18(7):1056\u201362.","journal-title":"Respirology"},{"issue":"3","key":"1882_CR8","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1164\/ajrccm.158.3.9710031","volume":"158","author":"S Loukides","year":"1998","unstructured":"Loukides S, Horvath I, Wodehouse T, Cole PJ, Barnes PJ. Elevated levels of expired breath hydrogen peroxide in bronchiectasis. Am J Respir Crit Care Med. 1998;158(3):991\u20134.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1882_CR9","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.rmed.2008.12.004","volume":"103","author":"A Shoemark","year":"2009","unstructured":"Shoemark A, Wilson R. Bronchial and peripheral airway nitric oxide in primary ciliary dyskinesia and bronchiectasis. Respir Med. 2009;103(5):700\u20136.","journal-title":"Respir Med"},{"issue":"2","key":"1882_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000106377","volume":"75","author":"D Makris","year":"2008","unstructured":"Makris D, Paraskakis E, Korakas P, Karagiannakis E, Sourvinos G, Siafakas NM, Tzanakis N. Exhaled breath condensate 8-isoprostane, clinical parameters, radiological indices and airway inflammation in COPD. Respiration. 2008;75(2):138\u201344.","journal-title":"Respiration"},{"key":"1882_CR11","doi-asserted-by":"crossref","unstructured":"Kelly C, Chalmers JD, Crossingham I, Relph N, Felix LM, Evans DJ, Milan SJ, Spencer S. Macrolide antibiotics for bronchiectasis. Cochrane Database Syst Rev. 2018;(3).","DOI":"10.1002\/14651858.CD012579.pub2"},{"key":"1882_CR12","doi-asserted-by":"crossref","unstructured":"Felix LM, Grundy S, Milan SJ, Armstrong R, Harrison H, Lynes D, Spencer S. Dual antibiotics for bronchiectasis. Cochrane Database Syst Rev. 2018;(6).","DOI":"10.1002\/14651858.CD012514.pub2"},{"key":"1882_CR13","first-page":"CD012590","volume":"9","author":"A Kaehne","year":"2018","unstructured":"Kaehne A, Milan SJ, Felix LM, Sheridan E, Marsden PA, Spencer S. Head-to-head trials of antibiotics for bronchiectasis. Cochrane Database Syst Rev. 2018;9:CD012590.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1882_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1378\/chest.122.1.213","volume":"122","author":"E Tagaya","year":"2002","unstructured":"Tagaya E, Tamaoki J, Kondo M, Nagai A. Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion. Chest. 2002;122(1):213\u20138.","journal-title":"Chest"},{"issue":"3","key":"1882_CR15","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/thorax.57.3.212","volume":"57","author":"J Wolter","year":"2002","unstructured":"Wolter J, Seeney S, Bell S, Bowler S, Masel P, McCormack J. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. Thorax. 2002;57(3):212\u20136.","journal-title":"Thorax"},{"issue":"10","key":"1882_CR16","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1136\/thx.2005.057950","volume":"61","author":"A Clement","year":"2006","unstructured":"Clement A, Tamalet A, Leroux E, Ravilly S, Fauroux B, Jais J-P. Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial. Thorax. 2006;61(10):895\u2013902.","journal-title":"Thorax"},{"issue":"7","key":"1882_CR17","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/S0954-6111(03)00042-8","volume":"97","author":"J Kadota","year":"2003","unstructured":"Kadota J, Mukae H, Ishii H, Nagata T, Kaida H, Tomono K, Kohno S. Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis. Respir Med. 2003;97(7):844\u201350.","journal-title":"Respir Med"},{"issue":"8","key":"1882_CR18","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJMoa1104623","volume":"365","author":"RK Albert","year":"2011","unstructured":"Albert RK, Connett J, Bailey WC, Casaburi R, Cooper JAD Jr, Criner GJ, Curtis JL, Dransfield MT, Han MK, Lazarus SC. Azithromycin for prevention of exacerbations of COPD. N Engl J Med. 2011;365(8):689\u201398.","journal-title":"N Engl J Med"},{"issue":"12","key":"1882_CR19","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1001\/jama.2013.2290","volume":"309","author":"DJ Serisier","year":"2013","unstructured":"Serisier DJ, Martin ML, McGuckin MA, Lourie R, Chen AC, Brain B, Biga S, Schlebusch S, Dash P, Bowler SD. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial. JAMA. 2013;309(12):1260\u20137.","journal-title":"JAMA"},{"issue":"12","key":"1882_CR20","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1001\/jama.2013.1937","volume":"309","author":"J Altenburg","year":"2013","unstructured":"Altenburg J, de Graaff CS, Stienstra Y, Sloos JH, van Haren EH, Koppers RJ, van der Werf TS, Boersma WG. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial. JAMA. 2013;309(12):1251\u20139.","journal-title":"JAMA"},{"issue":"6","key":"1882_CR21","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1164\/rccm.201303-0411CI","volume":"188","author":"PJ McShane","year":"2013","unstructured":"McShane PJ, Naureckas ET, Tino G, Strek ME. Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2013;188(6):647\u201356.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"1882_CR22","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.rmed.2008.06.005","volume":"102","author":"G Anwar","year":"2008","unstructured":"Anwar G, Bourke S, Afolabi G, Middleton P, Ward C, Rutherford R. Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. Respir Med. 2008;102(10):1494\u20136.","journal-title":"Respir Med"},{"issue":"6","key":"1882_CR23","first-page":"540","volume":"59","author":"G Davies","year":"2004","unstructured":"Davies G, Wilson R. Prophylactic antibiotic treatment of bronchiectasis with azithromycin. Thorax. 2004;59(6):540\u20131.","journal-title":"Thorax"},{"issue":"9842","key":"1882_CR24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","volume":"380","author":"C Wong","year":"2012","unstructured":"Wong C, Jayaram L, Karalus N, Eaton T, Tong C, Hockey H, Milne D, Fergusson W, Tuffery C, Sexton P. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet. 2012;380(9842):660\u20137.","journal-title":"Lancet"},{"key":"1882_CR25","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.","journal-title":"BMJ"},{"key":"1882_CR26","unstructured":"HigginsJPT G. Cochrane handbook for systematic reviews of interventions version 5.1. 0 [updated March 2011], The cochrane collaboration; 2011."},{"issue":"1","key":"1882_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials. 1996;17(1):1\u201312.","journal-title":"Control Clin Trials"},{"issue":"11","key":"1882_CR28","doi-asserted-by":"publisher","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","volume":"135","author":"LL Kjaergard","year":"2001","unstructured":"Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med. 2001;135(11):982\u20139.","journal-title":"Ann Intern Med"},{"issue":"11","key":"1882_CR29","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"8","key":"1882_CR30","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S2213-2600(13)70185-1","volume":"1","author":"PC Valery","year":"2013","unstructured":"Valery PC, Morris PS, Byrnes CA, Grimwood K, Torzillo PJ, Bauert PA, Masters IB, Diaz A, McCallum GB, Mobberley C. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med. 2013;1(8):610\u201320.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"1882_CR31","first-page":"493","volume":"41","author":"L Gang","year":"2018","unstructured":"Gang L, Chen Y, Ding F, Zhou X. The impact of different doses of azithromycin maintenance treatment on expiratory flow limitation and quality of life among stable patients with non-cystic fibrosis bronchiectasis. Chin J Postgrad Med. 2018;41(6):493\u20137.","journal-title":"Chin J Postgrad Med"},{"issue":"1","key":"1882_CR32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.athoracsur.2013.09.013","volume":"97","author":"AE Balci","year":"2014","unstructured":"Balci AE, Balci TA, Ozyurtan MO. Current surgical therapy for bronchiectasis: surgical results and predictive factors in 86 patients. Ann Thorac Surg. 2014;97(1):211\u20137.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"1882_CR33","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1089\/lap.2018.0694","volume":"29","author":"X Hao","year":"2019","unstructured":"Hao X, Dazhong L, Lei Y, Jiaying Z, Linyou Z. Surgical treatment of bronchiectasis: 5 years of experience at a single institution. J Laparoendosc Adv Surg Tech Part A. 2019;29(6):826\u201330.","journal-title":"J Laparoendosc Adv Surg Tech Part A"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-022-01882-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-022-01882-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-022-01882-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T19:27:28Z","timestamp":1701199648000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-022-01882-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,11]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1882"],"URL":"https:\/\/doi.org\/10.1186\/s13019-022-01882-y","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,11]]},"assertion":[{"value":"7 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"266"}}